Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Influence of immunomodulatory drugs on the gut microbiota

Translational research(2021)10.1016/j.trsl.2021.01.009Source: DataRank Database

Influence of immunomodulatory drugs on the gut microbiota is a research paper published in Translational research (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.48)OA: greenTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

William Ruff ORCID,Erin E. Longbrake ORCID,Inessa Cohen ORCID

Live enrichment

PubMed:33515779 PMC:PMC8184576 OpenAlex:https://openalex.org/W3122363818

National Institutes of Health

Grant: K23NS107624

National Institutes of Health

Grant: 5K23NS107624-04

Interactions between Gut Microbiome and B-Cell Depletion in Multiple Sclerosis

EMD Serono

FWCI

1.48

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8184576

publisherhttps://api.elsevier.com/content/article/PII:S1931524421000232?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931524421000232?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trsl.2021.01.009

Fields of Study

Gut microbiota and healthClostridium difficile and Clostridium perfringens researchPediatric health and respiratory diseases0301 basic medicine03 medical and health sciencesAdaptive ImmunityCell ProliferationCytokinesFemaleGastrointestinal MicrobiomeHost Microbial InteractionsHumansImmune Checkpoint InhibitorsImmunity, InnateImmunity, MucosalImmunologic FactorsImmunomodulationLymphocytesMaleModels, ImmunologicalSex FactorsTranslational Research, Biomedical

MeSH Terms

Gastrointestinal MicrobiomeHost Microbial InteractionsImmune Checkpoint InhibitorsFemaleHumansImmunity, InnateImmunologic FactorsLymphocytesMaleSex FactorsCytokinesModels, ImmunologicalImmunity, MucosalCell ProliferationAdaptive ImmunityImmunomodulationTranslational Research, Biomedical

Keywords

Gut floraMedicineImmunologyMaleHost Microbial InteractionsModels, ImmunologicalAdaptive ImmunityImmunity, InnateGastrointestinal MicrobiomeImmunomodulationTranslational Research, BiomedicalSex FactorsCytokinesHumansImmunologic FactorsFemaleLymphocytesImmune Checkpoint InhibitorsImmunity, MucosalCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Influence of immunomodulatory drugs on the gut microbiota

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)